Vetbromide 600 mg tablets for dogs Ireland - English - HPRA (Health Products Regulatory Authority)

vetbromide 600 mg tablets for dogs

regivet bv - potassium bromide - tablet - 600 milligram(s) - potassium bromide

Vetbromide 600 mg Tablets for Dogs United Kingdom - English - VMD (Veterinary Medicines Directorate)

vetbromide 600 mg tablets for dogs

regivet bv - potassium bromide - tablet - neurological agent antiepileptic - dogs

OSTEO REGIME CAPSULE Canada - English - Health Canada

osteo regime capsule

regime industries ltd. - manganese (manganese citrate); silicon (equisetum arvense); ascorbic acid (ascorbic acid); vitamin d3; vitamin b6 (pyridoxine hydrochloride); calcium (calcium citrate, calcium hvp chelate); magnesium (magnesium citrate, magnesium oxide); zinc (zinc citrate) - capsule - 2mg; .25mg; 25mg; 100unit; 5mg; 150mg; 75mg; 3mg - manganese (manganese citrate) 2mg; silicon (equisetum arvense) .25mg; ascorbic acid (ascorbic acid) 25mg; vitamin d3 100unit; vitamin b6 (pyridoxine hydrochloride) 5mg; calcium (calcium citrate, calcium hvp chelate) 150mg; magnesium (magnesium citrate, magnesium oxide) 75mg; zinc (zinc citrate) 3mg - vitamins & minerals

MULTI-REGIME CAPSULE Canada - English - Health Canada

multi-regime capsule

regime industries ltd. - beta-carotene (provitamin a); vitamin a (retinol palmitate); vitamin d3; vitamin b1 (thiamine hydrochloride); vitamin b2 (riboflavin); nicotinic acid; nicotinamide; vitamin b6 (pyridoxine hydrochloride); vitamin b12 (cyanocobalamin); d-pantothenic acid (calcium d-pantothenate); folic acid; biotin; ascorbic acid (ascorbic acid); vitamin e (d-alpha tocopheryl acid succinate); inositol; calcium (calcium carbonate, calcium citrate); magnesium (magnesium oxide, magnesium citrate); potassium (potassium citrate); zinc (zinc citrate); manganese (manganese citrate); iodine (kelp); chromium (chromium hvp chelate); selenium (selenium hvp chelate); vanadium (vanadium citrate); molybdenum (molybdenum citrate); silicon (horsetail) - capsule - 1250unit; 1250unit; 100unit; 4.25mg; 2.5mg; 5mg; 85mg; 10mg; 50mcg; 10mg; 0.2mg; 50mcg; 50mg; 50unit; 7.5mg; 75mg; 75mg; 10mg; 1.25mg; 0.5mg; 0.25mg; 50mcg; 25mcg; 7.5mcg; 2.5mcg; 0.5mg - beta-carotene (provitamin a) 1250unit; vitamin a (retinol palmitate) 1250unit; vitamin d3 100unit; vitamin b1 (thiamine hydrochloride) 4.25mg; vitamin b2 (riboflavin) 2.5mg; nicotinic acid 5mg; nicotinamide 85mg; vitamin b6 (pyridoxine hydrochloride) 10mg; vitamin b12 (cyanocobalamin) 50mcg; d-pantothenic acid (calcium d-pantothenate) 10mg; folic acid 0.2mg; biotin 50mcg; ascorbic acid (ascorbic acid) 50mg; vitamin e (d-alpha tocopheryl acid succinate) 50unit; inositol 7.5mg; calcium (calcium carbonate, calcium citrate) 75mg; magnesium (magnesium oxide, magnesium citrate) 75mg; potassium (potassium citrate) 10mg; zinc (zinc citrate) 1.25mg; manganese (manganese citrate) 0.5mg; iodine (kelp) 0.25mg; chromium (chromium hvp chelate) 50mcg; selenium (selenium hvp chelate) 25mcg; vanadium (vanadium citrate) 7.5mcg; molybdenum (molybdenum citrate) 2.5mcg; silicon (horsetail) 0.5mg - vitamins & minerals

NORTREL 7/7/7 (28 DAY REGIMEN)- norethindrone and ethinyl estradiol kit United States - English - NLM (National Library of Medicine)

nortrel 7/7/7 (28 day regimen)- norethindrone and ethinyl estradiol kit

physicians total care, inc. - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norethindrone 0.5 mg - nortrel™ 7/7/7 (norethindrone and ethinyl estradiol tablets, usp 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg) (21 day regimen and 28 day regimen) are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. method typical use perfect use oral contraceptives should not be used in women who currently have the following conditions: - thrombophlebitis or thromboembolic disorders - a past history of deep vein thrombophlebitis or thromboembolic disorders - cerebral vascular or coronary artery disease - known or suspected carcinoma of the breast - carcinoma of the endometrium or other known or susp

REGIMEN- ethyl alcohol gel United States - English - NLM (National Library of Medicine)

regimen- ethyl alcohol gel

pss world medical, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic to decrease bacteria on the skin. recommended for repeated use.

REGIMEN ANTIMICROBIAL- chloroxylenol soap United States - English - NLM (National Library of Medicine)

regimen antimicrobial- chloroxylenol soap

healthlink - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - antimicrobial - specially formulated for the sensitive skin of today's healthcare professional - protects hands from germs and bacteria - antimicrobial hand cleaner - for repeated washings on a daily basis

PERJETA Israel - English - Ministry of Health

perjeta

roche pharmaceuticals (israel) ltd - pertuzumab - concentrate for solution for infusion - pertuzumab 420 mg / 14 ml - pertuzumab - pertuzumab - early breast cancer perjeta is indicated for use in combination with trastuzumab and chemotherapy for: • the neoadjuvant treatment of patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer. • the adjuvant treatment of patients with her2-positive early breast cancer (node positive) at high risk of recurrence .metastatic breast cancerperjeta is indicated for use in combination with trastuzumab and docetaxel for the treatment of patients with her2-positive metastatic breast cancer who have not received prior anti-her2 therapy or chemotherapy for metastatic disease.

NECON 1/35 (28 DAY REGIMEN)- norethindrone and ethinyl estradiol United States - English - NLM (National Library of Medicine)

necon 1/35 (28 day regimen)- norethindrone and ethinyl estradiol

teva pharmaceuticals usa, inc. - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norethindrone 1 mg - necon 1/35 tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant® system depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year*  method (1) typical use† (2) perfect use‡ (3) (4) chance§  85 85 spermicides¶ 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal# 2 post-ovulation 1 capÞ  parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragmÞ  20 6 56 withdrawal 19 4 condomß  female (reality® ) 21 5 56 male 14 3 61

CAZIANT TRIPHASIC REGIMEN- desogestrel and ethinyl estradiol United States - English - NLM (National Library of Medicine)

caziant triphasic regimen- desogestrel and ethinyl estradiol

remedyrepack inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.1 mg - caziant (desogestrel and ethinyl estradiol tablets) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and implants, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year * method typical use † perfect use ‡ (1) (2) (3) (4) chance § 85 85 spermicides ¶ 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal # 2 post-ovulation 1 withdrawal 19 4 cap Þ parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragm Þ 20 6 56 condom